SCHEMBL19863036

SCHEMBL19863036

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c5oc6ccccc6c5cc(-c5cccc(-c6ccc7c8ccccc8c8ccccc8c7c6)c5)c43)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.33
MAPT P10636 5/20 0.33
TSHR P16473 3/20 0.33
PLA2G10 O15496 1/20 0.32
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
LMNA P02545 4/20 0.31
KDM4E B2RXH2 3/20 0.31
HSD17B10 Q99714 2/20 0.31
MAPK1 P28482 1/20 0.31
ALDH1A1 P00352 4/20 0.31
POLB P06746 2/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
PRKDC P78527 1/20 0.30
USP2 O75604 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863029 0.97 MAPT (0.34) ALOX5MAPTTSHRLMNAKDM4E
SCHEMBL19863037 0.96 MAPT (0.34) ALOX5MAPTTSHRPLA2G2APLA2G4A
SCHEMBL19863032 0.95 MAPT (0.34) MAPTTSHRPLA2G2APLA2G4ALMNA
SCHEMBL18594349 0.93 MAPT (0.35) ALOX5MAPTTSHRLMNAKDM4E
SCHEMBL19863034 0.92 ALOX5 (0.33) ALOX5MAPTTSHRPLA2G10PLA2G2A
SCHEMBL19863020 0.91 MAPT (0.34) ALOX5MAPTTSHRLMNAKDM4E
SCHEMBL18594053 0.91 MAPT (0.37) ALOX5MAPTTSHRLMNAKDM4E
SCHEMBL19863013 0.91 KDM4E (0.32) ALOX5MAPTTSHRPLA2G10PLA2G2A
SCHEMBL19863014 0.91 KDM4E (0.32) ALOX5MAPTTSHRKDM4EHSD17B10
SCHEMBL19863033 0.90 MAPT (0.34) ALOX5MAPTTSHRPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 ALOX5 1089/4885MAPT 746/4885TSHR 3741/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 ALOX5 1089/4885MAPT 746/4885TSHR 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.